Study to Compare the Pharmacokinetics and Pharmacodynamics of 6 mg RGB-02 to 6 mg Neulasta
Clinical trial NCT03146988 · COMPLETED
Trial details
- NCT number
- NCT03146988
- Sponsor
- Gedeon Richter Plc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-10
- Primary completion
- 2017-09-14
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.